# Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease

> **NCT03297515** · NA · COMPLETED · sponsor: **Ophthalmos Research and Education Institute** · enrollment: 32 (actual)

## Conditions studied

- Dry AMD
- Stargardt Disease 1

## Interventions

- **DIETARY_SUPPLEMENT:** Madeos
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03297515
- **Lead sponsor:** Ophthalmos Research and Education Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2020-09-22
- **Final completion:** 2020-09-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297515, "Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03297515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*